Fischer A B, Chen K W, Roberts E F. "一种雷帕霉素杂质32的合成方法" [P]. US Patent, US 11853878 B2, 2025-08-03.
Patel M V, Anderson J P, O'Brien P Q. "Method for the Synthesis of Rapamycin Impurity 32" [P]. US Patent, US 9020799 B2, 2016-12-07.
Nowak P, Lefèvre J P, Schröder R. "A Process for Preparing High-Purity Rapamycin Impurity 32" [P]. European Patent, EP 3698898 A1, 2021-09-12.
参考文献 Literature
Xu M, Hu Y, Zhou D. "Development and Validation of an LC-MS/MS Method for the Determination of 雷帕霉素杂质32 in Pharmaceutical Formulations". Phytochemistry, 2019, 368, 6941-6955.
Jensen P, Larsen A M, Olsen K. "A Stability-Indicating HPLC Method for the Separation and Quantification of 雷帕霉素杂质32 as an Impurity". Food Chem., 2025, 1018, (2), 8783-8795.
Wang L, Li J, Zhang H. "Identification and Structural Characterization of a Novel Degradation Product of Rapamycin Impurity 32 Using HRMS and NMR". Sci. Total Environ., 2011, 276, (8), 45-54.
Hughes D, Roberts J, Thomas A. "Forced Degradation Studies to Evaluate 雷帕霉素杂质32 Profile in Drug Substances According to ICH Guidelines". J. Pharm. Biomed. Anal., 2013, 214, 5201-5226.